Your browser is no longer supported. Please, upgrade your browser.
Sigma-Aldrich Corporation
IndexS&P 500 P/E33.15 EPS (ttm)4.17 Insider Own0.30% Shs Outstand119.43M Perf Week0.10%
Market Cap16.51B Forward P/E28.78 EPS next Y4.80 Insider Trans-11.78% Shs Float119.13M Perf Month0.12%
Income500.00M PEG4.48 EPS next Q1.09 Inst Own85.50% Short Float1.59% Perf Quarter0.94%
Sales2.79B P/S5.93 EPS this Y2.70% Inst Trans4.82% Short Ratio2.81 Perf Half Y2.15%
Book/sh26.30 P/B5.26 EPS next Y6.71% ROA12.50% Target Price121.50 Perf Year51.20%
Cash/sh8.49 P/C16.28 EPS next 5Y7.40% ROE16.30% 52W Range90.82 - 138.75 Perf YTD0.87%
Dividend0.92 P/FCF39.97 EPS past 5Y8.30% ROI14.10% 52W High-0.37% Beta0.82
Dividend %0.67% Quick Ratio3.20 Sales past 5Y5.30% Gross Margin51.00% 52W Low52.19% ATR0.39
Employees9300 Current Ratio4.60 Sales Q/Q3.10% Oper. Margin25.70% RSI (14)54.02 Volatility0.29% 0.26%
OptionableYes Debt/Eq0.14 EPS Q/Q2.80% Profit Margin18.00% Rel Volume1.10 Prev Close138.19
ShortableYes LT Debt/Eq0.10 EarningsApr 23 BMO Payout21.90% Avg Volume672.90K Price138.23
Recom2.80 SMA200.06% SMA500.31% SMA20011.50% Volume731,165 Change0.03%
Sep-22-14Reiterated MKM Partners Buy $95 → $140
Apr-25-14Reiterated Mizuho Neutral $85 → $95
Feb-07-14Reiterated UBS Sell $74 → $82
Oct-22-13Reiterated Mizuho Neutral $80 → $85
Sep-20-13Downgrade Robert W. Baird Outperform → Neutral
Jul-23-13Reiterated Mizuho Neutral $75 → $80
Apr-25-13Reiterated Mizuho Neutral $70 → $75
Feb-11-13Downgrade UBS Neutral → Sell $76 → $70
Feb-08-13Reiterated Mizuho Neutral $68 → $70
Feb-10-11Downgrade Longbow Buy → Neutral
Jan-12-11Downgrade KeyBanc Capital Mkts Buy → Hold
Oct-22-10Reiterated UBS Buy $68 → $70
Oct-22-10Reiterated Longbow Buy $65 → $72
Apr-14-10Upgrade UBS Neutral → Buy
Feb-11-10Upgrade Robert W. Baird Neutral → Outperform $60
Nov-06-09Initiated Jefferies & Co Hold $54
Aug-26-09Reiterated KeyBanc Capital Mkts Buy $54 → $60
Apr-24-09Reiterated UBS Neutral $40 → $44
Feb-04-09Downgrade Longbow Buy → Neutral
Dec-15-08Reiterated Robert W. Baird Neutral $46 → $40
Mar-23-15 04:27PM  Conatus Pharmaceuticals and BioReliance Present Key Emricasan Preclinical Safety Results at Society of Toxicology Annual Meeting at noodls
04:01PM  Conatus Pharmaceuticals and BioReliance Present Key Emricasan Preclinical Safety Results at Society of Toxicology Annual Meeting GlobeNewswire
Mar-20-15 03:58PM  Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of Aldrichimica Acta at noodls
03:00PM  Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of Aldrichimica Acta PR Newswire
11:51AM  Sigma-Aldrich (SIAL) Inks Distribution Agreement with Roche - Analyst Blog
Mar-19-15 12:20PM  Stifel executive sells over $1.4 million worth of stock: insider trading for March 10-16 at
07:20AM  Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche at noodls
07:00AM  Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche PR Newswire
Mar-17-15 09:38AM  VWR Funding, Inc. -- Moody's upgrades VWR's CFR to B1, rates new Euro senior notes B3; outlook stable at Moody's
Mar-12-15 03:14AM  Preliminary Results for the Year Ending 31 December 2014 at noodls
Mar-11-15 07:19AM  China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development at noodls
Mar-05-15 01:21AM  Notice of Results at noodls
Mar-03-15 02:11AM  German Merck sees slight gain in 2015 core profit Reuters
01:14AM  Merck KGaA sees slight increase in 2015 adj core earnings Reuters
Feb-24-15 07:31AM  Cerilliant Introduces Certified Spiking Solutions® of Tryptamines at noodls
07:00AM  Cerilliant Introduces Certified Spiking Solutions® of Tryptamines PR Newswire
Feb-23-15 12:26PM  Sigma-Aldrich (SIAL) Strikes New 52-Week High - Analyst Blog
Feb-19-15 01:04PM  SIGMA ALDRICH CORP Financials
Feb-18-15 07:30AM  Sigma® Life Science Releases Next-Gen Sequencing Oligos at noodls
07:00AM  Sigma® Life Science Releases Next-Gen Sequencing Oligos PR Newswire
Feb-16-15 01:00AM  Sigma-Aldrich Corporation (SIAL): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
Feb-13-15 10:08AM  Sigma-Aldrich Q4 Earnings Top on Organic Sales Gain - Analyst Blog
Feb-12-15 09:09AM  SIGMA ALDRICH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:35AM  Sigma-Aldrich (SIAL) Beats Q4 Earnings and Revenue Estimates - Tale of the Tape Zacks
07:07AM  Q4 2014 Sigma-Aldrich Corp Earnings Release - Before Market Open CCBN
06:21AM  Sigma-Aldrich tops Street 4Q forecasts AP
06:00AM  Sigma-Aldrich (NASDAQ - SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of $1.14 And Organic Sales Growth Of 7%. Declares $0.23 Per Share Quarterly Di PR Newswire
Feb-10-15 01:20PM  International Flavors & Fragrances: Earnings Surprise Call? - Analyst Blog Zacks
Feb-09-15 05:07PM  MeadWestvaco spin-off set to maximize shareholder value Market Realist
Feb-06-15 09:07AM  MeadWestvaco sales up $0.2 billion, cost savings on track Market Realist
Feb-03-15 12:10PM  Is Sigma-Aldrich (SIAL) Poised to Beat on Earnings in Q4? - Analyst Blog Zacks
Jan-29-15 07:00AM  Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, Establish CRISPR Core Lab Collaboration PR Newswire
Jan-26-15 02:40PM  Sigma-Aldrich Allies with VIB to Provide Research Tools - Analyst Blog Zacks
Jan-22-15 04:06PM  Sigma-Aldrich named among top sustainable companies worldwide at American City Business Journals
07:00AM  Sigma-Aldrich® and VIB Form Alliance to Provide Scientists with Enhanced and Faster Access to Novel Translational Research Tools PR Newswire
07:00AM  AGTC to Present at Phacilitate Cell & Gene Therapy Forum 2015 GlobeNewswire
Jan-21-15 04:49PM  Sigma-Aldrich® Named One of the Top 100 Most Sustainable Corporations in the World for the Second Consecutive Year PR Newswire
Jan-16-15 02:10PM  Sigma-Aldrich's SAFC Validates Dry Powder Media Unit - Analyst Blog Zacks
Jan-15-15 07:00AM  SAFC's State-of-the-Art Dry Powder Media Manufacturing Facility in Irvine, Scotland, Officially Opens Following Extensive Validation Process PR Newswire
Jan-11-15 06:22PM  Shire to buy NPS for $5.2 billion at USA TODAY
Dec-23-14 03:55PM  Sale of Sigma-Aldrich to Merck gets antitrust approval at American City Business Journals
09:44AM  Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance PR Newswire
Dec-19-14 04:00PM  Year in Review: Sigma-Aldrich acquired by Merck at American City Business Journals
Dec-11-14 07:00AM  Survey of Academic Translational Researchers Highlights Challenges to Reproducible Science PR Newswire
Dec-09-14 11:40AM  Sigma-Aldrich Shareholders Clears Takeover by Merck KGaA Zacks
Dec-08-14 08:30AM  Sigma-Aldrich® Again Named Top Company for Strengthening Communities through Science PR Newswire
Dec-05-14 04:02PM  SIGMA ALDRICH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial S EDGAR Online
12:30PM  Sigma-Aldrich Stockholders Approve Acquisition By Merck KGaA PR Newswire
Dec-04-14 07:00AM  Sigma-Aldrich Life Sciences Licenses Foundational CRISPR Patents from Broad Institute PR Newswire
Dec-03-14 10:40AM  Sigma-Aldrich Introduces Certified Reference Materials Zacks
07:00AM  Sigma-Aldrich Launches Comprehensive Flavors and Fragrances Standards Portfolio Aimed at Food & Beverage and Cosmetics Industries PR Newswire
Dec-02-14 07:00AM  Cerilliant Introduces Snap-N-Spike® ? Snap-N-Shoot® Certified Reference Materials for Cannabis Testing Applications PR Newswire
Nov-25-14 04:12PM  SIGMA ALDRICH CORP Files SEC form 8-K, Other Events EDGAR Online
Nov-21-14 05:22PM  SIGMA ALDRICH CORP Files SEC form 8-K, Other Events EDGAR Online
04:05PM  Sigma-Aldrich (SIAL) Is Today's Water-Logged And Getting Wetter Stock at TheStreet
Nov-19-14 09:45AM  Strong And Under The Radar Today: Sigma-Aldrich (SIAL) at TheStreet
Nov-18-14 12:00PM  GAMCO Investors opens a new position in Sigma-Aldrich Market Realist
Nov-05-14 05:49PM  Sigma-Aldrich (SIAL) Closes Cell Marque Acquisition Zacks
Nov-04-14 07:00AM  Sigma-Aldrich Completes Acquisition of Cell Marque PR Newswire
Nov-03-14 01:47PM  Minerals Technologies Digs Up A Winner With Buyout at Investor's Business Daily
09:03AM  Sigma-Aldrich Corporation Announces Filing Of Definitive Proxy Statement And Date Of Special Meeting Of Stockholders PR Newswire
Oct-29-14 07:00AM  SAFC Launches New Protein Quality Supplement to Increase N-linked Glycosylation PR Newswire
Oct-23-14 11:00AM  Sigma-Aldrich (SIAL) Q3 Earnings Meet Estimates, Profit Dips Zacks
09:15AM  Sigma-Aldrich meets 3Q profit forecasts AP
08:47AM  SIGMA ALDRICH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:07AM  Q3 2014 Sigma-Aldrich Corporation Earnings Release - Before Market Open CCBN
07:02AM  Sigma-Aldrich (NASDAQ - SIAL) Reports Q3 2014 Results With Sales Of $690 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Per Share Quarterly Dividend. PR Newswire
12:01AM  Sonos Lawsuit, Oxford University Press: Intellectual Property at Bloomberg
Oct-22-14 03:30PM  SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit In Connection With The Sale Of Sigma-Aldrich Corporation Business Wire
Oct-21-14 03:10PM  Will the Earnings Streak for Sigma-Aldrich (SIAL) Continue? Zacks
Oct-17-14 05:05PM  Sigma-Aldrich Launches In Vitro ADME, Toxicology Assays Zacks
Oct-16-14 07:00AM  BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy PR Newswire
Oct-15-14 05:46PM  Sigma-Aldrich (SIAL) Launches Kratom Alkaloid Solutions Zacks
11:28AM  11 stocks rising the most as the market heads toward a correction at MarketWatch
Oct-14-14 08:00AM  LAWSUIT ALERT: Andrews & Springer LLC Announces That a Law Firm Has Filed a Class Action Lawsuit Against Sigma-Aldrich Corporation - SIAL GlobeNewswire
07:00AM  Cerilliant Introduces Stable-Labeled Certified Reference Materials of Kratom Alkaloids PR Newswire
Oct-10-14 10:31AM  [video] Most resilient stocks at CNBC
Oct-08-14 03:00PM  Sigma-Aldrich Offers Ascentis Express 2.0 Micron UHPLC Zacks
10:02AM  Merger Boosts Materials ETFs Benzinga
Oct-07-14 08:35PM  SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Sigma-Aldrich Corporation -- SIAL GlobeNewswire
10:28AM  Stocks Slide At Starting Bell; Keurig Green Mountain Rises at Investor's Business Daily
07:00AM  Sigma-Aldrich Expands the Ascentis® Express U/HPLC Column Line with addition of 2.0 Micron Fused Core® Particle Columns PR Newswire
Oct-06-14 04:25PM  Robbins Arroyo LLP Announces That It Represents Investor in a Class Action Challenging Sigma-Aldrich's Buyout GlobeNewswire
11:30AM  Sigma-Aldrich to Acquire Cell Marque to Bolster IHC Business Zacks
06:00AM  Pittsburgh Law Office of Alfred G. Yates Jr., PC Reminds Ocwen Financial Corporation (OCN) Investors of Important Class Action Deadline, and Announces Investigations of Athlon Energy (ATHL), Bankrate (RATE), Dresser-Rand Group (DRC), Move ( PR Newswire
Oct-03-14 05:38AM  Sigma-Aldrich® Agrees To Acquire Cell Marque To Strengthen Immunohistochemistry Business PR Newswire
Sep-30-14 06:48PM  LAWSUIT ALERT: Andrews & Springer LLC Announces That a Law Firm Has Filed a Class Action Lawsuit Against Sigma-Aldrich Corporation -- SIAL GlobeNewswire
Sep-29-14 10:30AM  Lawsuit for Investors in Sigma-Aldrich Corporation (SIAL) Against Takeover Announced by Shareholders Foundation GlobeNewswire
Sep-26-14 11:00PM  SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Sigma-Aldrich Corporation And Encourages Investors To Contact The Firm For Additional Information Business Wire
04:42PM  10 biggest market-moving events of the week at MarketWatch
04:27PM  Reasons Why I Will Bet on Sigma Gurufocus
Sep-25-14 05:17PM  SIGMA ALDRICH CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
01:53PM  SIGMA-ALDRICH CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
11:01AM  Sigma-Aldrich Corp. Stockholders Encouraged to Contact Securities Law Firm about Takeover PR Newswire
Sep-24-14 06:46PM  Lifshitz & Miller Law Firm Announces Investigation of CommVault Systems, Inc., Dresser-Rand Group Inc., PDL BioPharma, Inc., Santander Consumer USA Holdings Inc., Sigma-Aldrich Corporation, and Viasystems Group, Inc. PR Newswire
04:42PM  Incredibly uncompetitive tax code: Pro CNBC
Sep-23-14 01:04PM  Sigma-Aldrich's $17 bln buyout seen as boost for lab supplier VWR Reuters
12:14PM  INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Sigma-Aldrich Corporation Regarding the Fairness of the Sale of the Company to Merck Business Wire
10:45AM  Ryan & Maniskas, LLP Announces Investigation of Sigma-Aldrich Corporation PR Newswire
09:31AM  Stock Market News for September 23, 2014 Zacks
Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide. The company provides chemical products, reagents, and kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. It offers media and critical raw materials for industrial cell culture, contract manufacturing services, pharmaceutical safety testing services, and organometallic precursors for semiconductor manufacturing. The company sells its products to pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies, and hospitals. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green Eric MarkEVP & President, ResearchMar 12Option Exercise64.3645,7162,942,16355,724Mar 16 05:08 PM
Green Eric MarkEVP & President, ResearchMar 12Sale138.2030,7604,251,03224,964Mar 16 05:08 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecMar 11Option Exercise76.1621,5651,642,46713,549Mar 13 11:48 AM
MILLER GEORGE LLOYDSVP, General Counsel & SecMar 11Sale137.897,095978,3304,539Mar 13 11:48 AM
Bertsch JanEVP & CFOMar 05Option Exercise0.006,000012,752Mar 09 12:20 PM
Marberry MichaelDirectorJan 02Option Exercise0.0068401,057Jan 09 04:42 PM
REINHARD J PEDRODirectorJan 02Option Exercise0.00684036,580Jan 09 04:43 PM
SPATZ D DEANDirectorJan 02Option Exercise0.00684059,640Jan 09 04:44 PM
TOAN BARRETT ADirectorJan 02Option Exercise0.00684029,457Jan 09 04:44 PM
MCCOLLUM LEEDirectorJan 02Option Exercise0.00684013,057Jan 09 04:43 PM
Nash Avi MDirectorJan 02Option Exercise0.00684047,730Jan 09 04:43 PM
PAUL STEVEN MDirectorJan 02Option Exercise0.0068408,257Jan 09 04:43 PM
Bergman Rebecca MDirectorJan 02Option Exercise0.0068405,857Jan 09 04:42 PM
CHURCH GEORGEDirectorJan 02Option Exercise0.0068404,657Jan 09 04:42 PM
SACHDEV RAKESHPresident & CEODec 18Option Exercise48.6111,842575,64043,319Dec 19 01:43 PM
Bertsch JanEVP & CFODec 18Option Exercise71.623,491250,02510,243Dec 19 01:42 PM
Green Eric MarkEVP & President, ResearchDec 18Option Exercise47.5115,900755,33415,318Dec 19 01:42 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 18Option Exercise62.497,950496,79618,136Dec 19 01:42 PM
Bertsch JanEVP & CFODec 17Option Exercise71.628,050576,54114,802Dec 18 03:54 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 17Option Exercise62.491,60099,98411,786Dec 18 04:00 PM
REINHARD J PEDRODirectorDec 17Option Exercise30.1210,000301,20037,820Dec 18 04:01 PM
SACHDEV RAKESHPresident & CEODec 17Option Exercise48.6120,301986,83251,778Dec 18 04:01 PM
SACHDEV RAKESHPresident & CEODec 16Option Exercise37.6331,6451,190,77062,041Dec 18 04:01 PM
KANAN MICHAEL FVP & Corporate ControllerDec 16Option Exercise40.792,600106,0547,438Dec 17 02:41 PM
Nash Avi MDirectorDec 15Option Exercise49.0126,9001,318,30642,773Dec 16 12:21 PM
SACHDEV RAKESHPresident & CEODec 15Option Exercise39.5837,4691,483,02368,946Dec 16 12:21 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 15Option Exercise48.617,943386,10918,129Dec 16 12:21 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 12Option Exercise53.988,970484,20119,156Dec 16 12:21 PM
MCCOLLUM LEEDirectorNov 05Option Exercise30.1210,000301,20022,373Nov 06 02:05 PM
MCCOLLUM LEEDirectorNov 05Sale135.2610,0001,352,58712,373Nov 06 02:05 PM
Green Eric MarkEVP & President, ResearchAug 08Option Exercise0.002,00009,436Aug 12 01:23 PM
KANAN MICHAEL FVP & Corporate ControllerAug 08Option Exercise0.002,00005,506Aug 12 01:23 PM
MILLER KAREN JSVP, Corp Develop & Corp CommJul 28Option Exercise48.617,943386,10912,952Jul 29 01:52 PM
MILLER KAREN JSVP, Corp Develop & Corp CommJul 28Sale103.197,943819,6595,009Jul 29 01:52 PM
Green Eric MarkEVP & President, ResearchMay 29Option Exercise31.035,900183,08011,980May 30 02:56 PM
Green Eric MarkEVP & President, ResearchMay 29Sale98.034,544445,4447,436May 30 02:56 PM
COTTIER GILLESEVP & Pres. SAFC CommercialMay 28Sale98.1012,0001,177,17410,528May 29 10:58 AM
WICKS FRANKEVP & Pres., AppliedApr 28Sale95.215,443518,24222,481Apr 30 02:31 PM